November 4, 2021
Biologics Consulting (BC) has an unprecedented record of achievement spanning almost three decades – a record of assisting clients to address nonclinical, clinical, product development, and regulatory compliance challenges. The cornerstone of this success is found in their team of consultants, subject-matter experts with industry and FDA experience. This experience allows the company to provide “insider” perspective on how best to navigate a new product from discovery through testing, nonclinical work, clinical trials, regulatory approvals, ultimately arriving at market in the most efficient manner. The Chase Group appreciates the opportunity to work alongside BC to continue building its CMC team in this highly competitive market. For more information, please contact: ken@chasegroup.com.
